Business Wire requests that the press release NewsItemId: 20231103762883 "A Proposal by Cole Capital Funds Seeks to Acquire 51% of all minority ownership shares of WeWork, Inc. for $9.00 per share in Cash" be removed.
https://finance.yahoo.com/news/proposal-cole-capital-funds-seeks-211200253.html
AbCellera (Nasdaq: ABCL) today presented new data on its T-cell engager (TCE) programs in two poster presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting. The data illustrate how AbCellera is leveraging its TCE platform to discover and develop immuno-oncology therapeutics for multiple tumor targets.
Ardelyx Inc., (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today shared positive data on the use of XPHOZAH® (tenapanor) in poster presentations at the American Society of Nephrology (ASN) Kidney Week 2023 meeting, currently being held in Philadelphia, Pennsylvania, and will showcase XPHOZAH in an Exhibitor Spotlight event. Ardelyx’s presence at Kidney Week 2023 will honor the memory of Derek Forfang, Chair of the Ardelyx Patient Advisory Council and a passionate advocate for patients with kidney disease.
XPHOZAH, the first and only phosphate absorption inhibitor, was approved by the U.S. Food and Drug Administration on October 17, 2023 to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy. XPHOZAH offers a different mechanism of action that blocks phosphate absorption at the primary pathway and is administered as a single tablet taken twice daily.
U.S. infant mortality rate rose 3%, with 20,538 deaths recorded in 2022, according to provisional data from the Centers for Disease Control and Prevention published Wednesday.
As Statista's Katharina Buchholz reports, the rate had been almost continuously falling since CDC records began in 1995, even though in an international comparison, the U.S. stays behind most developed nations in this metric.
Elliott Investment Management, the activist firm founded by Paul Singer, is suing the US Securities and Exchange Commission in an effort to obtain records on rule proposals that would impact his firm’s strategy of building stakes in public companies.
The firm has accused the Wall Street regulator of failing to hand over public records, including internal communications, that would shed light on the process around considering the rule proposals, according to a lawsuit filed Thursday in Washington federal court. The proposed rules, among other things, require greater disclosure when a security-based swap position surpasses a certain threshold.
Even before leaving the US for Israel, Secretary of State Antony Blinken acknowledged just how much the world’s focus had shifted from Hamas’s Oct. 7 attack to the Israeli military response.
“When I see a Palestinian child — a boy, a girl — pulled from the rubble of a collapsed building, that hits me in the gut as much as seeing a child in Israel or anywhere else,” Blinken told reporters on the tarmac in Washington. “This is something that we have an obligation to respond to.”
